John Kelley
Vorsitzender bei ACORDA THERAPEUTICS, INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von John Kelley
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ACORDA THERAPEUTICS, INC. | Independent Dir/Board Member | 01.12.2008 | - |
| Vorsitzender | 25.11.2019 | - | |
| Direktor/Vorstandsmitglied | 01.12.2008 | 25.11.2019 |
Karriereverlauf von John Kelley
Ehemalige bekannte Positionen von John Kelley
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.12.2013 | 03.04.2017 |
| Vorstandsvorsitzender | 14.11.2013 | 03.04.2017 | |
Phyxius Pharma, Inc.
 Phyxius Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of Tenax Therapeutics, Inc., Phyxius Pharma, Inc. provides pharmaceutical products. The company is based in Chester, NJ. The company was founded by Doug Randall, Douglas Hay, John P. Kelley. Phyxius Pharma was acquired by Life Newco, Inc. on November 13, 2013 for $32.66 million. | Direktor/Vorstandsmitglied | 01.01.2011 | 13.11.2013 |
| Vorstandsvorsitzender | 01.01.2011 | 13.11.2013 | |
| Gründer | 01.01.2011 | 13.11.2013 | |
| Präsident | 01.01.2011 | 13.11.2013 | |
| THE MEDICINES COMPANY | Geschäftsführer | 01.12.2004 | 01.10.2009 |
| Präsident | 01.12.2004 | 01.10.2009 | |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2000 | 01.09.2004 |
| Vertrieb & Marketing | 01.01.2000 | 01.09.2004 | |
| Hoechst Marion Roussel SA | Vertrieb & Marketing | 01.12.1999 | 01.12.1999 |
| Hoechst Marion Roussel, Inc. | Corporate Officer/Principal | 01.01.1998 | 01.01.1999 |
| Vertrieb & Marketing | 01.01.1995 | 01.01.1998 |
Ausbildung von John Kelley
| Wilkes University | Undergraduate Degree |
| Rockhurst University | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 9 |
| Frankreich | 2 |
Operativ
| Sales & Marketing | 3 |
| Director/Board Member | 3 |
| President | 2 |
Sektoral
| Health Technology | 7 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ACORDA THERAPEUTICS, INC. | Health Technology |
| TENAX THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
| Hoechst Marion Roussel, Inc. | |
| Hoechst Marion Roussel SA | Health Technology |
Phyxius Pharma, Inc.
Phyxius Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of Tenax Therapeutics, Inc., Phyxius Pharma, Inc. provides pharmaceutical products. The company is based in Chester, NJ. The company was founded by Doug Randall, Douglas Hay, John P. Kelley. Phyxius Pharma was acquired by Life Newco, Inc. on November 13, 2013 for $32.66 million. | Health Technology |
- Börse
- Insiders
- John Kelley
- Erfahrung
